OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$288M
AUM Growth
+$45.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1 +$7.5M
2 +$6.36M
3 +$6.24M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$4.68M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$4.28M

Top Sells

1 +$6.74M
2 +$6.12M
3 +$5.25M
4
MRUS icon
Merus
MRUS
+$5.07M
5
KROS icon
Keros Therapeutics
KROS
+$4M

Sector Composition

1 Healthcare 98.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$55.7M 19.38%
3,775,000
+431,183
2
$23.8M 8.29%
2,072,813
+36,262
3
$21.4M 7.44%
735,000
-75,000
4
$17.1M 5.94%
6,075,000
-390,000
5
$13.4M 4.66%
732,000
+60,700
6
$11.5M 3.98%
250,000
-13,000
7
$11.4M 3.97%
238,000
-83,300
8
$8.49M 2.95%
177,000
-13,000
9
$7.5M 2.61%
+540,000
10
$7.33M 2.55%
330,000
-20,700
11
$7.22M 2.51%
2,692,594
-15,473
12
$6.84M 2.38%
229,500
+20,000
13
$6.44M 2.24%
1,560,000
-101,784
14
$6.24M 2.17%
+923,200
15
$6.12M 2.13%
2,170,000
-351,000
16
$5.47M 1.9%
611,400
-23,600
17
$5.4M 1.88%
1,460,000
-1,655,000
18
$4.68M 1.63%
+417,500
19
$4.47M 1.55%
243,000
-5,000
20
$4.46M 1.55%
957,500
-197,500
21
$4.33M 1.51%
488,656
+91,156
22
$4.28M 1.49%
+80,456
23
$3.9M 1.36%
261,703
+128,203
24
$3.57M 1.24%
560,000
-3,500
25
$3.37M 1.17%
+167,500